GlassScriptPhysician profile
Randa Ghali
NPI 1730611161
$1,340.44
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.38 · 2021: $781 · 2022: $358 · 2023: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $164.92 | 2021 | |
| Xeris Pharmaceuticals, INC. | $136.39 | 2021-2023 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $96.15 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $89.46 | 2022 | |
| Novo Nordisk INC | $78.56 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.05 | 2022 | |
| Glaxosmithkline, LLC. | $58.70 | 2020-2022 | |
| Genzyme Corporation | $56.75 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $53.10 | 2023 | Jynarque |
| Abbvie INC. | $49.74 | 2021 | |
| Medtronic, INC. | $48.47 | 2021 | |
| Amgen INC. | $47.40 | 2021 | |
| Sanofi-Aventis U.S. LLC | $44.54 | 2020-2022 | |
| Biogen, INC. | $40.54 | 2021 | |
| Pfizer INC. | $39.81 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $38.38 | 2023 | Quviviq |
| Lilly USA, LLC | $31.76 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $30.17 | 2021 | |
| Arbor Pharmaceuticals, INC. | $25.31 | 2020-2021 | |
| Ucb, INC. | $20.94 | 2021 | |
| Horizon Therapeutics Plc | $20.30 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.60 | 2021 | |
| Exact Sciences Corporation | $18.71 | 2023 | Cologuard Collection Kit |
| Calliditas Therapeutics US INC. | $18.43 | 2022 | |
| Esperion Therapeutics, INC. | $14.78 | 2021 | |
| Allergan, INC. | $13.62 | 2020 | |
| Tanabe Pharma America, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randa Ghali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.